(2026). The resilient subset: Cancer stem cells at the core of immunotherapy resistance. Immunotherapy Advances.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"The Resilient Subset: Cancer Stem Cells at the Core of Immunotherapy Resistance."
Immunotherapy Advances 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"The Resilient Subset: Cancer Stem Cells at the Core of Immunotherapy Resistance."
Immunotherapy Advances, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.